![]() |
同义名 : | - |
CAS号 : | 2096999-92-5 | |
货号 : | A676958 | |
分子式 : | C27H31FN6O | |
纯度 : | 98% | |
分子量 : | 474.57 | |
MDL号 : | N/A | |
存储条件: |
Pure form Inert atmosphere, 2-8°C In solvent -20°C:3-6个月-80°C:12个月 |
|
溶解度 : | - |
生物活性 | |||
---|---|---|---|
描述 | JAK inhibitor 1 is an inhibitor of JAK extracted from patent US20170121327A1, compound example 283. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00494585 | Leukemia Myel... 展开 >>ofibrosis 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00494585 | - | Completed | - | - | |
NCT03425006 | Non Small Cell Lung Cancer | Phase 2 | Recruiting | June 2021 | United States, Pennsylvania ... 展开 >> University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Melissa Volpe 215-220-9703 Melissa.volpe@uphs.upenn.edu 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.11mL 0.42mL 0.21mL |
10.54mL 2.11mL 1.05mL |
21.07mL 4.21mL 2.11mL |